Lilly & Co Eli reported a 7.3% stake in Scribe Therapeutics SCTX · 1,388,161 sh

Trade details

Type: 5% stake report
Report: 13D
Stake: 7.3%
Last report: First report
Shares held: 1,388,161 sh
Class: Common stock, $0.001 par value per share
Stock: Scribe Therapeutics SCTX
Holder: Lilly & Co Eli
Event date: 26/07/23
Filed: 26/07/30

First 5%+ report · 7.3% stake

Scribe Therapeutics trades, last 26 weeks

What else happened in Scribe Therapeutics around then

Filed or reported within 30 days of the trade day · 06/23~08/22

Lilly & Co Eli's other 5% stake reports

Lilly & Co Eli
5% stakeAktis Oncology
5% stake
Aktis Oncology
AKTS
11.9% stake
6,344,114 sh
11.9% stake
Filed 01/15

Lilly & Co Eli reported a 7.3% stake in Scribe Therapeutics SCTX · 1,388,161 sh | Whalegun